Factual and Procedural Background
This appeal concerns a decision by the Information Commissioner regarding a request under the Freedom of Information Act 2000 (FOIA) for specific data related to a clinical trial known as the "PACE trial," conducted by Company A between 2005 and 2010. The trial was a large randomized controlled study evaluating treatments for Chronic Fatigue Syndrome/Myalgic Encephalopathy (CFS/ME), funded by a public research body and involving 641 patients.
The Appellee initially denied holding the requested information but later confirmed its possession, citing section 22 FOIA (information intended for future publication) as the basis for withholding it. The Appellant appealed the Information Commissioner's decision that the public interest lay in disclosing the information, arguing that withholding was justified to protect the integrity of the research and publication process. The appeal was determined on the papers, with a further party, the Second Respondent, joined to the proceedings.
Legal Issues Presented
- Whether it is reasonable in all the circumstances to withhold the requested information until the date of intended publication under section 22 FOIA.
- Whether the public interest in maintaining the exemption under section 22 FOIA outweighs the public interest in disclosure of the information.
Arguments of the Parties
Appellant's Arguments
- Publication under FOIA would result in loss of the opportunity to publish the data through peer-reviewed channels.
- Premature disclosure would harm publicly funded research by undermining the scientific process and academic freedom.
- Early release would limit the full and adequate dissemination of the project’s conclusions.
- Peer review is essential for scientific rigour, contextualising data, and preventing misinterpretation or misuse of raw data.
- Disclosure without peer review could devalue the research and diminish the return on public investment.
- Pre-publication of data could prejudice acceptance of articles by scientific journals, affecting publication opportunities.
- Academic freedom must be balanced with the public interest, especially where public funds are involved.
Second Respondent's Arguments
- The requested data relates to a published paper from 2011 and should be disclosed to allow proper scrutiny and challenge of the conclusions.
- Withholding the data creates a one-sided debate and prevents independent assessment of risks associated with treatments.
- The delay in publication is excessive and inconsistent with public research data sharing policies.
- The desire of journals for exclusive publication rights is a private commercial concern and should not outweigh public interest in disclosure.
- Disclosure of raw data prior to publication does not prevent subsequent peer-reviewed publication.
Table of Precedents Cited
No precedents were cited in the provided opinion.
Court's Reasoning and Analysis
The Tribunal accepted that the disputed information was held with a view to publication, engaging section 22 FOIA. It found the Commissioner’s original decision was influenced by a material factual error regarding the timing and completeness of the trial data publication. The Tribunal acknowledged that the trial was not completed until 2010 and that the data requested was part of ongoing peer-reviewed publications scheduled for release over 2012 and 2013.
The Tribunal analysed the reasonableness of withholding disclosure until publication, considering the peer review process, publication schedules, and the potential harm of premature disclosure. It accepted the Appellant’s argument that premature release could undermine scientific rigour, devalue the research, and jeopardize publication opportunities due to journal exclusivity policies.
The Tribunal rejected the argument that academic freedom includes the right to publish data regardless of the public interest, emphasizing that academic freedom is subject to the public interest test under FOIA.
While acknowledging the public interest in sharing publicly funded research data, the Tribunal found that the Appellant had made reasonable provision for timely publication and that the delay was justified by the need for rigorous scientific analysis and peer review. The Tribunal also noted that the Second Respondent’s concerns about delay were mitigated by the fact that some data had already been published and that the requested data was part of a structured publication timetable.
Balancing competing interests, the Tribunal concluded that maintaining the exemption was in the public interest to preserve the integrity and value of the research and its findings.
Holding and Implications
The Tribunal's final decision was to ALLOW THE APPEAL, holding that section 22 FOIA was properly applied and that withholding the requested information until its intended publication was reasonable and justified in the public interest.
The direct effect of this decision is that the Appellant may withhold the specified data until it is published through the peer-reviewed process. The decision does not set new precedent but reinforces the importance of balancing public interest in transparency with the need to protect the integrity of scientific research and publication processes.